HK1000663A1 - Crystalline form of the hydrochloride of 4-(5,6,7,8-tetrahydroimidazodi, 5-aapyridin-5-yl)-benzonitrile - Google Patents

Crystalline form of the hydrochloride of 4-(5,6,7,8-tetrahydroimidazodi, 5-aapyridin-5-yl)-benzonitrile

Info

Publication number
HK1000663A1
HK1000663A1 HK97102235A HK97102235A HK1000663A1 HK 1000663 A1 HK1000663 A1 HK 1000663A1 HK 97102235 A HK97102235 A HK 97102235A HK 97102235 A HK97102235 A HK 97102235A HK 1000663 A1 HK1000663 A1 HK 1000663A1
Authority
HK
Hong Kong
Prior art keywords
crystalline form
benzonitrile
hydrochloride
tetrahydroimidazodi
aapyridin
Prior art date
Application number
HK97102235A
Other languages
English (en)
Inventor
Ibrhamin Jutta
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HK1000663A1 publication Critical patent/HK1000663A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Lubricants (AREA)
  • Liquid Crystal Substances (AREA)
  • Pyridine Compounds (AREA)
  • Photoreceptors In Electrophotography (AREA)
HK97102235A 1990-01-12 1997-11-24 Crystalline form of the hydrochloride of 4-(5,6,7,8-tetrahydroimidazodi, 5-aapyridin-5-yl)-benzonitrile HK1000663A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH10090 1990-01-12

Publications (1)

Publication Number Publication Date
HK1000663A1 true HK1000663A1 (en) 1998-04-17

Family

ID=4179261

Family Applications (1)

Application Number Title Priority Date Filing Date
HK97102235A HK1000663A1 (en) 1990-01-12 1997-11-24 Crystalline form of the hydrochloride of 4-(5,6,7,8-tetrahydroimidazodi, 5-aapyridin-5-yl)-benzonitrile

Country Status (33)

Country Link
US (1) US5098911A (pl)
EP (1) EP0437415B1 (pl)
JP (1) JP2694186B2 (pl)
KR (1) KR100191360B1 (pl)
CN (1) CN1037966C (pl)
AT (1) ATE125809T1 (pl)
AU (1) AU638085B2 (pl)
BG (2) BG60033B2 (pl)
CA (1) CA2033937C (pl)
CZ (1) CZ279823B6 (pl)
DE (1) DE59106101D1 (pl)
DK (1) DK0437415T3 (pl)
DZ (1) DZ1482A1 (pl)
ES (1) ES2075399T3 (pl)
FI (1) FI94528C (pl)
GR (1) GR3017027T3 (pl)
HK (1) HK1000663A1 (pl)
HU (1) HU216192B (pl)
ID (1) ID964B (pl)
IE (1) IE67512B1 (pl)
IL (1) IL96879A (pl)
MA (1) MA22040A1 (pl)
MT (1) MTP1076B (pl)
NO (1) NO175747C (pl)
NZ (1) NZ236735A (pl)
PH (1) PH27601A (pl)
PL (3) PL166157B1 (pl)
PT (1) PT96447B (pl)
RO (1) RO107408B1 (pl)
RU (2) RU2021271C1 (pl)
SA (1) SA93140021B1 (pl)
TN (1) TNSN91001A1 (pl)
ZA (1) ZA91229B (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW208013B (pl) * 1990-03-01 1993-06-21 Daiichi Co Ltd
EP0457716A1 (de) * 1990-04-20 1991-11-21 Ciba-Geigy Ag Naphthalinderivate
TW224461B (pl) * 1990-09-18 1994-06-01 Ciba Geigy Ag
CH683151A5 (de) * 1991-04-24 1994-01-31 Ciba Geigy Ag Antikonzeption bei weiblichen Primaten ohne Beeinflussung des menstruellen Zyklus.
JP2914324B2 (ja) * 1995-10-23 1999-06-28 味の素株式会社 ピペリジン誘導体の結晶並びにその製造中間体及び製造方法
CN103189053A (zh) 2010-09-01 2013-07-03 艾尼纳制药公司 用于体重控制的5-ht2c激动剂的调节释放剂型
MX2013002418A (es) 2010-09-01 2013-08-01 Arena Pharm Inc Administracion de lorcaserina a individuos con daño renal.
UA114803C2 (uk) * 2012-01-17 2017-08-10 Новартіс Аг ФОРМИ І СОЛІ ДИГІДРОПІРОЛ[1,2-c]ІМІДАЗОЛІЛЬНОГО ІНГІБІТОРА АЛЬДОСТЕРОНСИНТАЗИ АБО АРОМАТАЗИ
CN114853755A (zh) 2016-10-27 2022-08-05 达米安制药股份公司 醛固酮合酶抑制剂
WO2018078049A1 (en) 2016-10-27 2018-05-03 Damian Pharma Ag Aldosterone synthase inhibitor
WO2019211394A1 (en) 2018-05-03 2019-11-07 Damian Pharma Ag R-fadrozole for use in the treatment of aldostonerism

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4617307A (en) * 1984-06-20 1986-10-14 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors
US4588732A (en) * 1982-12-21 1986-05-13 Ciba-Geigy Corporation Certain imidazo(1,5-a)pyridine derivatives and their use as thromboxane synthetase inhibitors

Also Published As

Publication number Publication date
MTP1076B (en) 1991-09-30
FI910126A0 (fi) 1991-01-09
RO107408B1 (ro) 1993-11-30
RU2021271C1 (ru) 1994-10-15
CA2033937C (en) 2001-03-13
CS9100055A2 (en) 1991-08-13
JPH04210982A (ja) 1992-08-03
DE59106101D1 (de) 1995-09-07
PL288653A1 (en) 1991-12-16
HUT56568A (en) 1991-09-30
ID964B (id) 1996-09-30
ATE125809T1 (de) 1995-08-15
CN1037966C (zh) 1998-04-08
MA22040A1 (fr) 1991-10-01
HU216192B (en) 2001-03-28
DZ1482A1 (fr) 2004-09-13
PL166500B1 (pl) 1995-05-31
IL96879A (en) 1995-06-29
FI94528C (fi) 1995-09-25
EP0437415B1 (de) 1995-08-02
FI910126A (fi) 1991-07-13
HU910084D0 (en) 1991-08-28
JP2694186B2 (ja) 1997-12-24
RU2088584C1 (ru) 1997-08-27
CA2033937A1 (en) 1991-07-13
SA93140021B1 (ar) 2006-07-11
NO175747C (no) 1994-11-30
US5098911A (en) 1992-03-24
NO910137L (no) 1991-07-15
KR910014376A (ko) 1991-08-31
PL166157B1 (pl) 1995-04-28
BG61489B2 (bg) 1997-09-30
NO910137D0 (no) 1991-01-11
PT96447A (pt) 1991-10-15
AU638085B2 (en) 1993-06-17
NZ236735A (en) 1992-10-28
AU6928091A (en) 1991-07-18
ZA91229B (en) 1991-08-28
PT96447B (pt) 1998-09-30
EP0437415A3 (en) 1992-01-22
IL96879A0 (en) 1992-03-29
FI94528B (fi) 1995-06-15
IE67512B1 (en) 1996-04-03
KR100191360B1 (ko) 1999-06-15
PL167164B1 (pl) 1995-08-31
DK0437415T3 (da) 1995-09-18
TNSN91001A1 (en) 1992-10-25
PH27601A (en) 1993-08-31
NO175747B (no) 1994-08-22
CZ279823B6 (cs) 1995-07-12
BG60033B2 (en) 1993-07-15
GR3017027T3 (en) 1995-11-30
EP0437415A2 (de) 1991-07-17
IE910103A1 (en) 1991-07-17
CN1055739A (zh) 1991-10-30
ES2075399T3 (es) 1995-10-01

Similar Documents

Publication Publication Date Title
PT78682B (en) Process for preparing novel 8-chloro-1,5-benzothiazepine derivatives and of pharmaceutical compositions containing the same
ES8503667A1 (es) Un procedimiento para la preparacion de nuevos derivados de 2-oxo-imidazolina.
HK1000663A1 (en) Crystalline form of the hydrochloride of 4-(5,6,7,8-tetrahydroimidazodi, 5-aapyridin-5-yl)-benzonitrile
EP0291799A3 (en) Dioxyalkylenearyl-dihydropyridines and their intermediary compounds, process for their preparation and their use
HUT45518A (en) Process for producing 1,5-benzothiazepine derivatives and pharmaceutics comprising these compounds
EP0257572A3 (en) Thyronin derivatives
ES2071873T3 (es) Procedimiento para la preparacion de compuestos de 1-oxa-3,8-diaza-4-oxo-espiro(4,5)decano.
HUT36120A (en) Process for producing substituted pyrido/1,2-c/imidazo/1,2-a/benzimidazols and pharmaceutical compositions containing them
PL246418A1 (en) Process for preparing n-/3-trifluoromethylphenyl/-n'-propargylpiperazine
DE3365933D1 (en) Substituted thienobenzodiazepinones, process for their preparation and medicines containing these compounds
EP0367036A3 (en) Substituted 3-aminosydnonimines, process for their preparation and their use
IL103527A0 (en) Process for the preparation of substituted indoles
GB2282810A (en) Process for the preparation of clavulanic acid
GR3024391T3 (en) Cyclised analogs of metabolites of fatty acids, process for their preparation and pharmaceutical compositions containing them.

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20110102